olmesartan/amlodipine 40/5 apotex olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablet blister pack
arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; pregelatinised maize starch; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination (see dosage and administration).
pharmacor olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack
pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; silicified microcrystalline cellulose; stearic acid; pregelatinised maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
pharmacor olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets blister pack
pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; pregelatinised maize starch; stearic acid; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
akm olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack
pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; stearic acid; silicified microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
olmesartan amlo hct gppl 40/5/25 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/25 mg tablet blister pack
arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.
olmetan amlo hct 40/5/25 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/25 mg tablet blister pack
arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.
akm olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets blister pack
pharmacor pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; stearic acid; croscarmellose sodium; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
olmes amlo hct 40/5/25 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/25 mg tablet blister pack
arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.
olmetan amlo hct 40/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/12.5 mg tablet blister pack
arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.
olmesatan amlodipine gppl 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablet blister pack
gm pharma international pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; silicified microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination (see dosage and administration).